News and Announcements
Facing Rejections in Capital Raising: A Guide for Startups
- Published September 25, 2023 11:00PM UTC
- Publisher Wholesale Investor
- Categories Capital Raising Tips
Raising capital is often cited as one of the most formidable challenges that startup founders face. The journey is fraught with rejection, emotional turmoil, and unexpected obstacles. These obstacles are a normal part of the journey, and understanding them can provide valuable insights for entrepreneurs.
Going Through Emotions
The emotional rollercoaster that accompanies the capital raising process is a common experience for many founders. Feelings of excitement, anticipation, and ultimately, disappointment, are shared by those seeking investment for their ventures.
Not Getting a Response
One of the most disheartening aspects of seeking investment is the lack of response from potential investors. This frustrating experience is a reality for many, and handling the silence requires resilience and determination.
Getting Ghosted by an Investor
Being ghosted by an investor after initial interest can be particularly painful. Insights into why this might happen and how to move forward without losing momentum are essential for those navigating the investment landscape.
Learning from the Rejections and the Whole Process
Rejections are not merely setbacks; they are learning opportunities. Analysing each rejection to understand what went wrong and how to improve is vital for growth and success in the capital raising process.
Conclusion
The challenges of capital raising offer invaluable insights for startup founders. Whether just beginning the journey or having faced multiple rejections, perseverance and learning from failures can lead to success. The reminder that facing obstacles in capital raising is normal, and that growth comes from understanding and overcoming these challenges, is a message that resonates with entrepreneurs across the globe.
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
